SCHEMBL19460133

SCHEMBL19460133

COc1c(C)cc(C(=O)C(=O)NC(C)C)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 5/20 0.50
▸ TAS1R1 Q7RTX1 5/20 0.50
▸ ALDH1A1 P00352 4/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ TUBB1 Q9H4B7 2/20 0.41
▸ TUBB4A P04350 1/20 0.41
▸ TUBB P07437 1/20 0.41
▸ TUBA3C P0DPH7 1/20 0.41
▸ TUBA1B P68363 1/20 0.41
▸ TUBA4A P68366 1/20 0.41
▸ TUBB4B P68371 1/20 0.41
▸ TUBB3 Q13509 1/20 0.41
▸ TUBB2A Q13885 1/20 0.41
▸ TUBB8 Q3ZCM7 1/20 0.41
▸ TUBA3E Q6PEY2 1/20 0.41
▸ TUBA1A Q71U36 1/20 0.41
▸ TUBA1C Q9BQE3 1/20 0.41
▸ TUBB6 Q9BUF5 1/20 0.41
▸ TUBB2B Q9BVA1 1/20 0.41
▸ PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20079471 0.83 ALDH1A1 (0.60) ALDH1A1ALOX12TUBB1TUBB4ATUBB
SCHEMBL14486846 0.73 TAS1R3 (0.57) TAS1R3TAS1R1ALDH1A1ALOX12TUBB1
SCHEMBL1739400 0.72 CA1 (0.54) TAS1R3TAS1R1ALDH1A1PPARAL3MBTL1
SCHEMBL11435411 0.72 TUBB4A (0.54) TAS1R3TAS1R1ALDH1A1TUBB1TUBB4A
SCHEMBL4730730 0.70 ALDH1A1 (0.57) TAS1R3TAS1R1ALDH1A1TUBB1TUBB4A
SCHEMBL10730456 0.70 TAS1R3 (0.47) TAS1R3TAS1R1ALDH1A1ALOX12TUBB1
SCHEMBL312132 0.70 TPMT (0.55) TAS1R3TAS1R1ALDH1A1KDM4EKMT2A
SCHEMBL2796551 0.70 LMNA (0.52) TAS1R3TAS1R1ALDH1A1TUBB1TUBB4A
SCHEMBL1003340 0.69 ALDH1A1 (0.57) TAS1R3TAS1R1ALDH1A1ALOX12TUBB1
Hydrochloric Acid SCHEMBL11851061 0.69 TPMT (0.53) TAS1R3TAS1R1ALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9951058-B2 Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) 2018-04-24 — — US disclosed
US-9790197-B2 Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) 2017-10-17 — — US disclosed
Send feedback